» Authors » Julien Haroche

Julien Haroche

Explore the profile of Julien Haroche including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 247
Citations 7142
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicario R, Fragkogianni S, Pokrovskii M, Meyer C, Lopez-Rodrigo E, Hu Y, et al.
Neuron . 2025 Mar; PMID: 40081365
Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are clonal myeloid disorders associated with mitogen-activated protein (MAP)-kinase-activating mutations and an increased risk of neurodegeneration. We found microglial mutant clones in...
2.
Pegoraro F, Peyronel F, Errahmani M, Catamero F, Papo M, Cohen-Aubart F, et al.
JAMA Oncol . 2025 Feb; PMID: 40014337
No abstract available.
3.
Haroche J, Azoulay L
Blood . 2025 Feb; 145(8):790-791. PMID: 39976946
No abstract available.
4.
Razanamahery J, Idbaih A, Papo M, Robelin F, Emile J, Audia S, et al.
Haematologica . 2025 Jan; PMID: 39815815
Not available.
5.
Abeykoon J, Go R, Azoulay L, Haroche J
Br J Haematol . 2024 Nov; 206(2):792-794. PMID: 39535303
Lin et al. report the long-term follow-up of a phase II trial involving 95 adult patients with Langerhans cell histiocytosis (LCH), investigating the combination of methotrexate and cytarabine (MA). After...
6.
Salmon-Divon M, Meyuchas R, Shpilberg O, Okon E, Benhamida J, Yabe M, et al.
Leukemia . 2024 Nov; 39(2):516-519. PMID: 39516372
No abstract available.
7.
Papo M, Cappy P, Degachi A, Woerther P, Saal C, Charlotte F, et al.
Rheumatology (Oxford) . 2024 Oct; PMID: 39468734
Objectives: Lymphadenopathy is a classical manifestation of systemic lupus erythematosus (SLE) flare, occurring in approximately half of patients during the course of the disease. Lymphadenopathy in SLE is frequently associated...
8.
Ozkaya N, Melloul Benizri S, Venkataraman G, Karai L, Fraitag S, Razanamahery J, et al.
Blood Adv . 2024 Oct; 8(22):5796-5805. PMID: 39361706
Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly understood entity characterized by accumulation of CD1a+/S100+ histiocytes (as Langerhans cell histiocytosis [LCH]) but with reduced-absent expression of Langerin/CD207. We...
9.
Emile J, Pluchart C, Azoulay L, Quere B, Venton G, Filhon B, et al.
J Hematop . 2024 Aug; 17(4):289-293. PMID: 39212850
No abstract available.
10.
Vicario R, Fragkogianni S, Pokrovskii M, Mayer C, Lopez-Rodrigo E, Hu Y, et al.
bioRxiv . 2024 Aug; PMID: 39131366
Langerhans cell Histiocytosis (LCH) and Erdheim-Chester disease (ECD) are clonal myeloid disorders, associated with MAP-Kinase activating mutations and an increased risk of neurodegeneration. Surprisingly, we found pervasive PU.1 microglia mutant...